Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128152 · ClinicalTrials.gov registry record · NA
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
A NA study of Severe Stroke or Similar Neurological Muscle Weakness, sponsored by Shirley Ryan AbilityLab.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT02128152 is a NA study of Severe Stroke or Similar Neurological Muscle Weakness that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02128152, a NA study of Severe Stroke or Similar Neurological Muscle Weakness, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and effectiveness of the Ekso robotic exoskeleton in persons affected by a severe stroke. * Primary Objectives: * To determine if a structured high-dosage exoskeleton training program (EXTP) results in clinically significant gains in walking recovery in individuals affected by severe stroke. * To determine whether timing of EXTP delivery (i.e., sub-acute vs. chronic) and severity (non-ambulators vs. limited house-hold ambulators) affects the improvement in gait speed and overall function following the EXTP training protocol. * To determine whether maintenance or further improvement in gait speed can be achieved by an intensive follow-up program of either a traditional rehabilitation program (TRP) or extended EXTP. * Secondary Objectives: * To determine the effect on functional walking endurance as assessed by the 6 minute walk test and 10 meter walk test, in high-dosage exoskeleton training program (EXTP) vs. traditional rehabilitation program (TRP) carried in an outpatient setting for post stroke individuals. * To determine the effect on functional balance, as assessed by the Berg Balance Scale, Functional Gait Assessment and Five times sit to stand measure as assessed by the 6 minute walk test, in high-dosage exoskeleton training program (EXTP) vs. traditional rehabilitation program (TRP) carried in an outpatient setting for post stroke individuals. * To determine the effect on stroke recovery, as assessed by the step counter of task specific training in high-dosage exoskeleton training program (EXTP) vs. traditional rehabilitation program (TRP) carried in an outpatient setting
Conditions Studied
Interventions
- DEVICE Ekso exoskeleton
Study Locations (1)
Illinois
- Rehabilitation Institute of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-02 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02128152
The ClinicalTrials.gov registry entry for NCT02128152 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Severe Stroke or Similar Neurological Muscle Weakness appearing as the primary indexed condition, and to 1 intervention - of which Ekso exoskeleton is the first listed.
NCT02128152 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02128152 about?
NCT02128152 is a clinical study titled "Mobility Training Using Exoskeletons for Functional Recovery After Stroke". The purpose of this study is to assess the safety and effectiveness of the Ekso robotic exoskeleton in persons affected by a severe stroke. * Primary Objectives: * To determine if a structured high-dosage exoskeleton training program (EXTP) results in clinically significant gains in walking reco...
What is the current status of trial NCT02128152?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2014-02. Estimated completion is 2025-12.
What conditions does trial NCT02128152 study?
This clinical trial studies the following conditions: Severe Stroke or Similar Neurological Muscle Weakness.
What interventions are being tested in trial NCT02128152?
The interventions under investigation include: Ekso exoskeleton (DEVICE).
Who is sponsoring clinical trial NCT02128152?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128152 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.